Spinal Cord Trauma Treatment Market, Global Outlook and Forecast 2023-2030 help@statsmarketresearch.com
(+1)-646-781-7170 (Int'l) (+91)-916-916-4321 (Asia)
Report Overview: • A spinal cord injury (SCI) is damage to the spinal cord that causes temporary or permanent changes in its function. Symptoms may include loss of muscle function, sensation, or autonomic function in the parts of the body served by the spinal cord below the level of the injury. • The global key manufacturers of Spinal Cord Trauma Treatment include Acorda Therapeutics, Inc., Asterias Biotherapeutics, ReNetX Bio., BioArctic AB, BioTime, Inc., InVivo Therapeutics, Kringle Pharma, Inc., Novartis AG and Pfizer Inc., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
©All Rights Reserved, Stats Market Research
Market Value: • The global Spinal Cord Trauma Treatment market was valued at US$ 2458.9 million in 2022 and is projected to reach US$ 3009.4 million by 2029, at a CAGR of 2.9% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
CAGR of 2.9% (2022 – 2030)
©All Rights Reserved, Stats Market Research
By Types: • Complete Spinal Cord Injuries • Partial Spinal Cord Injuries
©All Rights Reserved, Stats Market Research
By Applications:
Hospitals
Trauma Centers
©All Rights Reserved, Stats Market Research
Get in touch
(+1)-646-781-7170 (Int'l)
(+91)-916-916-4321 (Asia)
help@statsmarketresearch.com
www.statsmarketresearch.com
Full Report Url:
https://www.statsmarketresearch.com/download-freesample/7829333/global-spinal-cord-trauma-treatmentforecast-2023-2030-980 ©All Rights Reserved, Stats Market Research